Stories Tagged as
Vaccine distribution
A view of the vaccine rollout from rural America
by
Kai Ryssdal
and Maria Hollenhorst
Jan 8, 2021
Dr. Scott Anzalone, a family physician and president of the school board in Logan, Ohio, talks about pandemic challenges.
Restaurant workers in D.C. next up for vaccination
Jan 8, 2021
If you are a restaurant worker in Washington, D.C., you will be eligible to get a COVID-19 vaccination in February.
Retail pharmacy chains will face challenges for vaccine rollout
Jan 5, 2021
Pharmacies like CVS and Walgreens have to consider storage requirements, more staffing and store layout for vaccine distribution.
Relief and confusion as COVID-19 vaccines reach nursing homes
Dec 23, 2020
The vaccine rollout will be a heavy lift for many homes that have been dealing with outbreaks, equipment shortages and labor challenges.
Teachers move near the front of the line for vaccine
Dec 21, 2020
It's up to states to decide if teachers qualify as frontline essential workers, given that they're able to work remotely.
COVID-19 vaccine rollout in Indonesia faces multiple challenges
Dec 21, 2020
Indonesia, home to the world's largest Muslim population, is awaiting emergency authorization for China's Sinovac vaccine.
The "cold chain" used by Dippin' Dots and COVID-19 vaccine
by
Kai Ryssdal
and Sean McHenry
Dec 17, 2020
The pelletized ice cream snack has to be shipped at extremely low temperatures. So does the Pfizer-BioNtech vaccine.
For public good, not for profit.
Dry ice makers pressed to meet demand for vaccine distribution
by
Erika Beras
Dec 11, 2020
Supercold storage is essential. But Is there enough dry ice to go around as the coronavirus vaccine is shipped around the country?
Which essential workers should be prioritized for vaccines?
Dec 11, 2020
Pilots, bankers, meatpacking plants and teachers all say they should be first for limited doses.
Vaccine delivery across the country faces complex supply chain challenges
by
Scott Tong
Dec 10, 2020
Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.